Skip to main content
. Author manuscript; available in PMC: 2021 Sep 8.
Published in final edited form as: Mol Pharm. 2020 Jul 28;17(9):3581–3588. doi: 10.1021/acs.molpharmaceut.0c00606

Figure 3.

Figure 3.

Radioactive HPLC profiles (A) of 99mTc(CO)3-NOTA-GGNle-CycMSHhex (NOTA) and 99mTc(CO)3-NODAGA-GGNle-CycMSHhex (NODAGA). The retention time of 99mTc(CO)3-NOTA-GGNle-CycMSHhex and 99mTc(CO)3-NODAGA-GGNle-CycMSHhex was 15.6 and 12.8 min, respectively. Specific binding (B) of 99mTc(CO)3-NOTA-GGNle-CycMSHhex and 99mTc(CO)3-NODAGA-GGNle-CycMSHhex on B16/F10 melanoma cells with (white) and without (black) peptide blockade.